We used genetic knockdown (KD) and global sequencing approaches in human AML cell lines, including a number of cytogenic AML subtypes, to characterise novel mechanisms of NFATC2‐regulated oncogenic maintenance in AML, indicative of a putative targetable mechanism for further study. This evidence concerns the gene NFATC2 and acute myeloid leukemia.